Clorox (NYSE:CLX – Get Free Report) had its price objective boosted by investment analysts at JPMorgan Chase & Co. from $167.00 to $171.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 6.67% from the stock’s current price.
A number of other research analysts have also weighed in on CLX. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and raised their price objective for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and raised their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. DA Davidson raised their target price on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Finally, Evercore ISI decreased their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. Four analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, Clorox currently has an average rating of “Hold” and an average target price of $156.54.
Read Our Latest Research Report on Clorox
Clorox Stock Performance
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.49 EPS. On average, equities analysts forecast that Clorox will post 6.87 earnings per share for the current year.
Hedge Funds Weigh In On Clorox
Hedge funds have recently added to or reduced their stakes in the stock. Brooklyn Investment Group lifted its stake in Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares during the period. Prospera Private Wealth LLC bought a new position in shares of Clorox during the third quarter valued at approximately $27,000. Continuum Advisory LLC increased its holdings in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares during the period. Quarry LP raised its stake in Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after buying an additional 114 shares in the last quarter. Finally, Carolina Wealth Advisors LLC purchased a new stake in Clorox during the third quarter worth $48,000. 78.53% of the stock is currently owned by institutional investors.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Recommended Stories
- Five stocks we like better than Clorox
- How to Plot Fibonacci Price Inflection Levels
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- What is a Special Dividend?
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Why is the Ex-Dividend Date Significant to Investors?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.